CRISPR/Cas9 silences gene associated with high cholesterol levels
This marks the first time researchers have delivered CRISPR/Cas9 repressors for targeted therapeutic gene silencing in adult animal models
Stay updated with breaking news from Charles Gersbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This marks the first time researchers have delivered CRISPR/Cas9 repressors for targeted therapeutic gene silencing in adult animal models
On Wednesday, Christopher Nelson, 21st Century Assistant Professor of Biomedical Engineering, will discuss his work on adapting CRISPR-based tools for correcting genetic diseases.
Tune Therapeutics presented their first results at ASGCT, revealing successful epigenetic editing in non-human primates.
Tune Therapeutics presented their first results at ASGCT, revealing successful epigenetic editing in non-human primates.
Duke chemist Matthew L. Becker and biomedical engineers Charles Gersbach and Warren M. Grill have been elected Fellows of the National Academy of Inventors (NAI) class of 2022. They are among 169